Refine your search results with filters

Additional Specialty
Years of Experience
Level of Expertise

Last Updated: 10/19/2022

Looking for the best doctor for you?
Start Here
Learn about our expert tiers
Learn more
Learn about our doctor expertise tiers.
If you have a rare or serious condition, you may want to seek advice from the best doctor you can find.
In most cases, seeking advice from top-tier doctors may not be necessary.
  • Global leaders in their field
  • Publish in medical journals frequently
  • Speak at conferences
  • Participate in clinical trials
  • Likely to work with cutting edge treatments
  • Likely to hold leadership positions in their organization
  • Leaders in their field
  • Strong research portfolio
  • Likely to work with cutting edge treatments
  • Likely to be a leader in their field regionally
  • Excellent at diagnosing and treating conditions.
  • Treat many patients and have extensive experience in their field.
  • May not publish, speak at conferences, or participate in clinical trials.
  • Primarily treat patients rather than focus on research.
  • May be specialists or primary care physicians.
  • Have great experience in diagnosing and treating conditions.
  • Majority of doctors fall within this rating.
Find a second opinion
Find now
Enter a Location
6 doctors found
Sort By
Find a second opinion
Learn about our expert tiers

To see more doctors, please expand your search radius or view related conditions below.

Classical Hodgkin Lymphoma, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)

Showing 1-6 of 6

Last Updated: 10/19/2022

Hodgkin’s lymphoma, also known as Hodgkin’s disease, is one of the most common types of lymphatic cancer (cancer of the immune system) and is one of the most curable forms of cancer. Lymphoma is a term used to describe cancers that affect the lymph nodes and lymph system (immune system), which is also composed of many blood vessels and organs, including the spleen, areas of the intestines, thymus gland, tonsils, and adenoids. Hodgkin’s lymphoma has two main types: 1) Classical Hodgkin’s lymphoma, and 2) nodular lymphocyte-predominant Hodgkin’s lymphoma. Classical Hodgkin’s lymphoma is the most common type of Hodgkin’s lymphoma and is characterized by large, abnormal cells (Reed-Sternberg cells) in the lymph nodes and is divided into four subtypes: 1) nodular sclerosis Hodgkin’s lymphoma, 2) mixed cellularity Hodgkin’s lymphoma, 3) lymphocyte-depleted Hodgkin’s lymphoma, and 4) lymphocyte-rich Hodgkin’s lymphoma. Nodular sclerosis Hodgkin’s lymphoma is rare, grows more slowly than classic Hodgkin’s lymphoma, is characterized by large, abnormal cells called popcorn cells, is treated differently, and has a better chance of cure. Hodgkin’s lymphoma is categorized by the following stages: Stage I – The lymphoma is only in one lymph node region or a single organ. Stage II – The lymphoma is in two lymph node regions or has spread (metastasized) to one organ and its nearly lymph nodes but is limited to either above or below the diaphragm. Stage III – The lymphoma has spread to the lymph nodes both above and below the diaphragm and may have spread (metastasized) to tissue near an organ, lymph nodes, or the spleen. Stage IV – In this advanced stage of lymphoma, the cancer has spread (metastasized) to several areas of one or more organs or tissues and affects the lymph nodes and other areas of the body, such as the lungs, liver, or bone. Hodgkin’s lymphoma is further described as either A (no significant symptoms) or B (significant symptoms, such as chronic fever, unexplained weight loss, and severe night sweats).

Behind the List

MediFind is the industry authority on identifying the leading medical experts and latest research in order to help patients facing complex health challenges, including , make better health decisions. Leveraging our expertise in natural language processing and machine learning across thousands of diseases, we uncover physicians who are leading authorities on . MediFind identifies these experts using proprietary world-class models that assess over 2.5 million global doctors based on a range of variables, including research leadership, patient volume, peer standing, and connectedness to other experts. Learn more about our methodology by exploring how MediFind works.